U.S. Attorney Christopher Christie is defending his decision to give special treatment to the first hip-and-knee implant manufacturer to cooperate in an investigation of an alleged industry practice of inducing doctors to use products by financial incentives.
For its cooperation, Christie’s office allowed Stryker Orthopedics Inc. of Mahwah, N.J., to sign a nonprosecution agreement. The four others signed deferred prosecution agreements, are paying a total of $310 million in fines and have agreed to abide by corporate integrity agreements for five years.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
